Active Pharmaceutical Ingredients

Eli Lilly will set up four new pharmaceutical manufacturing facilities in the US for $27 billion to further bolster its supply chains, according to a statement.

Eli Lilly to set up four manufacturing facilities in US for $27 billion

Eli Lilly will set up four new pharmaceutical manufacturing facilities in the US for $27 billion to further bolster its supply chains, according.

by HealthQuill
February 26, 2025
0 Comments

Novo Nordisk plans to invest 42 million Danish kroner ($6 billion) in Denmark to create new capacities for making active pharmaceutical ingredients and expand its portfolio within serious chronic diseases.

Drugs Health Pharma

Novo Nordisk plans $6 billion investment to expand in Denmark

HQ Team November 10, 2023: Novo Nordisk plans to invest 42 million Danish kroner ($6 billion) in Denmark to create new capacities for.

by HealthQuill
November 10, 2023
0 Comments

Denmark’s Novo Nordisk will invest 15.9 billion kroner ($2.30 billion) to expand its Hillerød production facility in the country to make new active pharmaceutical ingredients.

Drugs Health Pharma

Novo Nordisk to invest $2.3 billion to expand Danish facility

HQ Team June 13, 2023: Denmark’s Novo Nordisk will invest 15.9 billion kroner ($2.30 billion) to expand its Hillerød production facility in the.

by HealthQuill
June 13, 2023
0 Comments

Dr. Reddy’s Laboratories, an Indian maker of generics and active pharmaceutical ingredients, has completed the acquisition of Mayne Pharma’s U.S. generic prescription portfolio.

Drugs Health Medical Pharma

Dr. Reddy’s completes Mayne Pharma’s U.S. portfolio buyout

H.Q. Team April 7, 2023: Dr. Reddy’s Laboratories, an Indian maker of generics and active pharmaceutical ingredients, has completed the acquisition of Mayne.

by HealthQuill
April 7, 2023
0 Comments

About Us

Contact Info

Eli Lilly to set up four manufacturing facilities in US for $27 billion

Novo Nordisk plans $6 billion investment to expand in Denmark

Novo Nordisk to invest $2.3 billion to expand Danish facility

Dr. Reddy’s completes Mayne Pharma’s U.S. portfolio buyout

About Us

Contact Info

Follow Us

Eli Lilly to set up four manufacturing facilities in US for $27 billion

Novo Nordisk plans $6 billion investment to expand in Denmark

Novo Nordisk to invest $2.3 billion to expand Danish facility

Dr. Reddy’s completes Mayne Pharma’s U.S. portfolio buyout